Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Beyond Air Inc (XAIR)

Beyond Air Inc (XAIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,719
  • Shares Outstanding, K 86,370
  • Annual Sales, $ 1,160 K
  • Annual Income, $ -60,240 K
  • EBIT $ -50 M
  • EBITDA $ -47 M
  • 60-Month Beta 0.25
  • Price/Sales 3.28
  • Price/Cash Flow N/A
  • Price/Book 0.74
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.06
  • Most Recent Earnings $-0.15 on 02/10/25
  • Next Earnings Date 06/23/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 598.13% ( +242.12%)
  • Historical Volatility 77.92%
  • IV Percentile 84%
  • IV Rank 39.25%
  • IV High 1,355.43% on 09/26/24
  • IV Low 108.92% on 05/28/24
  • Put/Call Vol Ratio 0.13
  • Today's Volume 52
  • Volume Avg (30-Day) 22
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 4,468
  • Open Int (30-Day) 4,577

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.15
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +61.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1622 +12.21%
on 05/15/25
0.2500 -27.20%
on 04/21/25
-0.0485 (-21.04%)
since 04/16/25
3-Month
0.1622 +12.21%
on 05/15/25
0.3984 -54.32%
on 02/19/25
-0.2070 (-53.21%)
since 02/14/25
52-Week
0.1622 +12.21%
on 05/15/25
1.4850 -87.74%
on 06/24/24
-1.2030 (-86.86%)
since 05/16/24

Most Recent Stories

More News
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)

XAIR : 0.1820 (+1.45%)
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

XAIR : 0.1820 (+1.45%)
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

XAIR : 0.1820 (+1.45%)
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

XAIR : 0.1820 (+1.45%)
NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders

XAIR : 0.1820 (+1.45%)
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

XAIR : 0.1820 (+1.45%)
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

XAIR : 0.1820 (+1.45%)
Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

XAIR : 0.1820 (+1.45%)
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

XAIR : 0.1820 (+1.45%)
Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

XAIR : 0.1820 (+1.45%)

Business Summary

Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden...

See More

Key Turning Points

3rd Resistance Point 0.2076
2nd Resistance Point 0.1985
1st Resistance Point 0.1902
Last Price 0.1820
1st Support Level 0.1728
2nd Support Level 0.1637
3rd Support Level 0.1554

See More

52-Week High 1.4850
Fibonacci 61.8% 0.9797
Fibonacci 50% 0.8236
Fibonacci 38.2% 0.6675
Last Price 0.1820
52-Week Low 0.1622

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar